Pfizer wants India to order COVID-19 vaccine before pursuing approval

Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots – one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.

India’s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company’s application was made in early December. The regulator has also declined to accept the company’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.

Keep reading

5,000 National Guard Troops to Stay in DC Through March, Some Returning Home

Following a controversial deployment to the nation’s capital to defend and protect the inauguration, at least 5,000 National Guard members will remain in Washington through mid-march. 

“As we continue to work to meet the final post-inauguration requirements, the National Guard has been requested to continue supporting federal law enforcement agencies with 7,000 members and will draw down to 5,000 through mid-March,” Maj. Matt Murphy told the Epoch Times. 

“We are providing assistance such as security, communications, medical evacuations, logistics and safety support to state, district and federal agencies,” he added. 

One-thousand of these National Guard troops are from Virginia, according to Virginia National Guard officials. 

“Virginia National Guard personnel are remaining on duty following the Presidential Inauguration at the request of local and federal authorities, and they will remain on duty until those agencies no longer require our direct support,” Maj. Gen. Timothy P. Williams said. 

Keep reading